This mechanism means AOD-9604 does not require appetite suppression to be effective, making it suitable for individuals who do not struggle with appetite control or who cannot tolerate the gastrointestinal side effects common with GLP-1 agonists
PLoS One (2011) 6(4):e19478
From 2008-2010, Sanofi-Aventis Acomplia (selective CB1 antagonist) and Abbott Laboratories Meridia (NE/5-HT reuptake inhibitor)--both also designed to suppress appetite--were pulled from the market over similar cardiac safety concerns
So, 2ml is 200 units
Yes, you can take them on an empty stomach, but some people may experience mild nausea
We serve patients from: Kempton Park, Boksburg, Benoni, Alberton, Tembisa, Alexandra, Midrand, Springs, Daveyton, Kwa-Thema, Soweto, Fourways, Sandton, Vosloorus, Dawn Park, and Johannesburg Central